chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very lightly picked nose, not scratching the skin, and got a nose bleed; Nose was dry; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo171) via an unspecified route of administration in the left arm on 24May2021 at 10:30 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin, sulfa drugs and pineapple. Concomitant medications included vitamin b nos (VITAMIN B), ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D), magnesium (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), curcumin (MANUFACTURER UNKNOWN) and multi (as reported); all for unspecified indication from unknown date. The patient previously took ammonium chloride;diphenhydramine hydrochloride;menthol;sodium citrate (COSINE) for unspecified indication from unknown date and experienced drug allergy. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo175) via an unspecified route of administration in the left arm on 03May2021 at 10:30 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The clinical course was reported as follows: on 25May2021 at 11:00, the patient very lightly picked nose, not scratching the skin, and got a nose bleed. It lasted a minute or so. It was enough to drop out, not just a little residue. The patient clotted quickly and it stopped with pressure. The patient's nose was dry and got this kind of nosebleeds as a little kid, but this was excessive and patient believed it was related to the shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event very lightly picked nose, not scratching the skin, and got a nose bleed was recovered on 25May2021. The clinical outcome of the event nose was dry was recovered on an unknown date of May2021.   No follow-up attempts are possible. No further information is expected
Sore throat began a few hours after vaccination and lasted for 24 hours. Fever of up to 100.2 degrees F and moderate body aches and chills began about 12 hours after vaccination and lasted for about 18 hours. Some slight nausea and loss of appetite as well. Treated with 400 mg ibuprofen. All symptoms subsided by about 32 hours after vaccination.
Very stiff neck and back on side of injection. Extreme difficulty moving head up, down or turning head left or right.
Patient was given half dose of the Moderna Bivalent Booster, patient was to receive full dose 0.5mcg.
redness and swelling on the right  arm that is reported to have started just above the inside of the elbow and then worked progressed up the inside of the arm to just above the vaccination site, soreness
This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 04-OCT-2017, the patient was vaccinated with a dose of expired VAQTA lot # M002268 with expiration date of 20-SEP-2017, intramuscularly, for prophylaxis (strength, dose and frequency were not reported). No adverse effects were reported.
Narrative:  Pt received second COVID-19 vaccine dose 3/27/21. Reported feeling weak and lethargic after receiving vaccine and fell out of shower chair 3/28; admitted for evaluation. Developed isolated fever of 101.4 F on 3/30. Notes suggest sx possibly post-vaccine related. Sx resolved and pt discharged 3/31.
approx 28 hrs p/vax pt vomited bright red blood; then later vomited dark red blood;  approx 20 ml bright red blood found in diaper; hospitalized 6 days; upper GI series neg; stool series for blood pos; repeat neg;
Information has been received from staff from a physician's office concerning an 18 year old female with severe allergies to numerous things (dogs, cats, doxycycline, sulfa, CEFZIL and ADACEL) who on 29-MAY-2008 was vaccinated with a first dose of GARDASIL by intramuscular injection in the arm (lot number not reported). Concomitant therapy included YASMIN, ZYRTEC and SUDAFED. Almost immediately after receiving the vaccine, the patient experienced numbness and tingling in her arm where the injection was given. The patient also experienced redness underneath her eyes which described as red streaks (one going vertically and the other horizontally). The patient also had a reaction to ADACEL, but specifics were unknown. Unspecified medical attention was sought. Subsequently, the patient recovered from all the events. Additional information has been requested.
About 2 days after vaccination pt. reports pain in elbow and numbness/tingling in middle finger and ring finger.
I received the shot on 4/10. First 24 hours I had a slight fever and headache. Treated with Acetaninophhen. Since that time, I had relatively mild symptoms 4/11 - 4/13. Mostly fatigue.  On 4/14, I had a sudden increase in heart rate, dizziness, tingling sensation in all arms and legs and weakness in my limbs/grip. This prompted me to visit the ER. They ran numerous blood tests amd scans on me but found no abnormalities. Various unusual symptoms have continued to persist since 4/14.  For brief moments I feel fine.  At other times I have experience fatigue, diziness/vertigo, rapid heart rate, pins and needles feeling in my left hand and left leg.  Left leg numbness/tightness and heaviness. The fingers on my left hand sometimes move involuntarily.  And my anxiety has also gone up during this time. Tonight it has migratee to my left foot, where I have numbness in several of my toes.  I'm looking for advice. Should I be concerned? Should these symptoms still be occurring 11 days after receiving my shot?  It has been very distressing and there seem to be very few people who have knowledge on this subject.  My care providers keep saying to self monitor and contact them if symptoms worsen. The problem is symptoms don't necessarily worsen, they just migrate from one area of my body to another.  The numbness comes and goes in maybe 1-2 hour intervals.
Initial unsolicited report received from a Pharmacist on 22 September 2015. This case involves a 66 years old female patient who was vaccinated with a second dose of FLUZONE HD (batch number: UI454AA), (dose was unknown) via intramuscular route in the left deltoid on 20 September 2015. The patient's medical history and concomitant medications were unknown. It was reported that, on 21 September 2015 (1 day after vaccination) the patient had events as red, itchy, warm 3 inches below injection site and wraps around arm and patient also states that she had a similar site reaction last year that lasted for 1 week. Lab data and corrective treatments were unknown. The outcome of the events were unknown. List of documents held by sender: none.
pt recv vax 10OCT98 & later that day pt devel an inj site rxn characterized by redness, pain, mild swelling & warmth;
flutter and AFIB; anxiety; threw up; her heart was racing; This is a spontaneous report from a contactable consumer (patient mother) reported patient (reporter daughter). A 22-year-old female patient received first dose of BNT162B2 (Pfizer covid-19 vaccine, Solution for Injection, Lot Number: EN6205, Expiration date: Unknown), via an unspecified route in the right arm on 07Apr2021 (age at vaccination: 22-year-old) as a single dose for covid-19 immunization. Medical history included extreme immune system and seizures that only lasted about 2 years when she was a baby. The patient concomitant medications were not reported. Patient had issues when she was born, she was 3 weeks post term, she was adopted and when all the kids would get sick, she would always get the sickest. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unknown date, few days later she felt something and thought it was anxiety, 2 weeks after vaccination from 15May2021, she woke herself up threw up and saying that her heart was racing around 8:30 in the morning, so she went and got their finger monitor, and her heart rate was out of control, so they took her to the emergency room. They tried to get her heart rate down with medications and sent us to an electro physicist, and the rest is history. Patient has been an athlete her whole life, has been in great shape with no heart problems. She was taken to the ER and they captured flutter on the EKG and AFIB issues. Later she was hospitalized and ended up having cardiac surgery about a week ago at 13:00 (16Jun2021 to 17Jun2021). Caller states that her daughter was doing really well, they had to do an ablation. Caller states they saw the cardiologist today, her daughter may have bouts of palpitations, but has had nothing since 3 days after the surgery. Caller wanted to know if AFIB has been reported as a reaction. She received her second shot of BNT162B2 (Pfizer covid-19 vaccine, Solution for Injection, Lot Number: EN6199) in the right arm on 28Apr2021. They said she will recover completely, but it will take about 3 months. She will have to be followed by a cardiologist. The patient underwent lab test and procedure on 15May2021 which included flutter on the EKG. The clinical outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Red, swollen, pain and a node the size of her palm. Went to Dr. and he prescribed medication and treated her for cellulitis.
Pink at injection site; Pain in back; Not feeling good; Whole body hurting; Pain in muscles; Right arm hurting, swollen; Right arm red, itchy; Right arm hurting, swollen; Right arm red, itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BACK PAIN (Pain in back), FEELING ABNORMAL (Not feeling good), VACCINATION SITE DISCOLOURATION (Pink at injection site), ERYTHEMA (Right arm red, itchy) and PAIN IN EXTREMITY (Right arm hurting, swollen) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A2A and 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2011, the patient experienced ERYTHEMA (Right arm red, itchy) and PERIPHERAL SWELLING (Right arm hurting, swollen). On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Right arm hurting, swollen) and PRURITUS (Right arm red, itchy). On 11-Mar-2021, the patient experienced BACK PAIN (Pain in back), FEELING ABNORMAL (Not feeling good), PAIN (Whole body hurting) and MYALGIA (Pain in muscles). On 16-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Pink at injection site). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, BACK PAIN (Pain in back), FEELING ABNORMAL (Not feeling good), VACCINATION SITE DISCOLOURATION (Pink at injection site), ERYTHEMA (Right arm red, itchy), PAIN IN EXTREMITY (Right arm hurting, swollen), PERIPHERAL SWELLING (Right arm hurting, swollen), PRURITUS (Right arm red, itchy), PAIN (Whole body hurting) and MYALGIA (Pain in muscles) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Echocardiogram: other (normal) other.          No Concomitant medications was reported
initial reaction about 10 hours after 2nd shot - fever, chills, headache ,tired and sore injection site - most gone in 36 hours  More worried about current problems - pain started in thumb and two fingers in right hand about a week after shot in right arm -  progressed to elbow then shoulder.  Still aches and limits use of hand and arm.  Problems with handwriting, typing, grip and pain in elbow.
Lethargy; Pain at injection site; Congestion; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Feb2021 at 09:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, anxiety, depression and atrial fibrillation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline hydrochloride (ZOLOFT), loratadine (CLARITIN), bupropion hydrochloride (WELLBUTRIN) and nadolol (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Feb2021 at 13:00 the patient experienced lethargy, pain at injection site and congestion (nasal congestion). Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lethargy, pain at injection site and congestion was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
On 8/23/18, PM: arm swollen below the injection site. On 8/24/18: upper arm swollen to softball size, very warm tender, painful and red spot or "rash" noted below injection site and grew to 3 inches by 3 inches. On 8/25/18: ill with fever, chills, more painful arm and headache. Called her doctor 8/27/18, but did not receive a call back. As of today 8/30/18, she is mostly back to normal but is not planning to receive the second dose of SHINGRIX.
This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was received 44 days ago) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was received 44 days ago). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was received 44 days ago) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.
Patient reports severe fatigue, and feeling unwell; as well as warm red spot at site of vaccination and a lump under the skin at the vaccine site; patient also reports redness in the face
Chest discomfort intermittent for 3 hours after vaccine admin, and then again later that evening.  muscle twitching  lasting for 4 to 5 days post injection moderate
SOB and tingling in her tongue and throat about 15-20 minutes after. Taken to Urgent Care.
Information has been received from a physician a patient who was vaccinated with a dose of Rotateq vaccine (human-bovine). The physician reported that the patient subsequently developed a fever, diarrhea, vomiting, dehydration and was admitted to the hospital. While hospitalized, the patient tested positive for rotavirus. The patient was discharged from the hospital " a couple days later". At the time of this report, the outcome was unknown. Additional information has been requested.
fever-temp 102 inc, dec, devel 10JUL96;rt quadriceps firm & swollen, very tender to touch for about one wk;checked @ 15JUL96 by MD;
1:25pm presented self accompanied by husband after leaving vaccination observation area, at front gate with already relieved feeling of not being well.  Stated, "I think I was just nervous."  Skin W/D, resp even, B/P 106/63, HR 88, O2Sat 97%.  EMS onsite advised if symptoms return call 911.
Rt deltoid area warm, firm and swollen with redness that is now spreading. 14 x 12 cm on 06/16/2018.
acute Guillain-Barre Synd; hospitalized 5 days-recvd 5 rounds of immune globulin
after receiving the 1st dose of Moderna covid-19 vaccine, while patient is sitting for observation, patient started to  feel itchy, I grabbed Benadryl syrup to administer by patient stated he feel he is going to faint and started. I supported him to lay him on the ground, while laying him on the ground I called for associate nearby for code to call for help and I grabbed Epi-pen and I was about to administer. During this time patient was still responsive and did not lose conscious. Before I administered the Epi-Pen, patient stated he was doing ok, he did not lose conscious so I did not administer the Epi-pen. another pharmacist applied a cold compress as patient was sweating. after few minutes laying on the floor patient said he was feeling better so we put him in a chair.  while being seated in the chair patient stated he feels his throat is tightening  and I administered 10 ml of OTC Benadryl Syrup. after few minutes patient stated his throat is getting better. Patient remained seated for 30 minutes for observation and kept applying cold compresses. After 30 minutes, patient stated he was doing better, I advised him to contact his physician and he should get the second dose after consulting with his physician and he needs to take it in a medical office
Felt tired; Felt anxious; Face was numb; Face was tingling; Problems sleeping; Lips were tingling; Trouble swallowing; Lips started to swell; A spontaneous report was received from a female nurse patient, of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273)  experienced Felt tired, Felt anxious, Face was numb, Face was tingling, Problems sleeping, Lips were tingling, Trouble swallowing and Lips started to swell.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 29-Dec-2020, approximately one day prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (lot: unknown) for prophylaxis of COVID-19 infection.  On 30-Dec-2020, the patient began feeling tired, felt anxious, her face was numb and tingling, had problems sleeping, her lips were tingling and swollen, and she had trouble swallowing.  Treatment included diphenhydramine.  She "wasn't sure if her problems with the sleep had to do with her taking diphendramine".  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
it was reported that a 6 mont old female infant received TRIPEDIA and ACTHIB vaccines on December 1, 1998. Reportedly 25 minutes after the shots the patient started vomiting violently and became lethargic-pale, limp and flaccid. When seen in office the patient had pale lips. Reportedly was given BENADRYL 12.5 mg/IM and epinephrine 0.1 cc/SC. The patient reportedly recovered from this experience. No additional information was provided from correspondence received at Aventis Pasteru Inc. on 20-Apr-2000. This case is closed.
R anterior thigh 4x 5 redness & 3 x 4 cm induration
Lack of efficacy; Tested positive for COVID-19/only had fatigue/Feels a little weak; This spontaneous case was reported by a consumer and describes the occurrence of DRUG INEFFECTIVE (Lack of efficacy) and COVID-19 (Tested positive for COVID-19/only had fatigue/Feels a little weak) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced DRUG INEFFECTIVE (Lack of efficacy) and COVID-19 (Tested positive for COVID-19/only had fatigue/Feels a little weak). At the time of the report, DRUG INEFFECTIVE (Lack of efficacy) outcome was unknown and COVID-19 (Tested positive for COVID-19/only had fatigue/Feels a little weak) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Nov-2021, SARS-CoV-2 test: positive (Positive) Tested positive for COVID-19.         No concomitant medications were reported No treatment medications were reported.  The patient had symptoms of COVID only a couple of days earlier to the diagnosis date and currently feels a little bit weak, otherwise almost recovered.  This case concerns a 88-year-old male patient with no details on relevant medical history, who experienced the unexpected non serious event/AESI of COVID-19 after mRNA- 1273 Moderna vaccine (Moderna COVID-19 Vaccine / Spikevax). Additionally, Drug ineffective was captured. The event occurred approximately 8 months after the second dose of mRNA- 1273 vaccine with an appropriate schedule of vaccination (window between doses 26 days). The disease was mild, clinical manifestations were fatigue and asthenia. The rechallenge is not applicable due to the nature of the event . It is noted that patient´s age is a risk factor for severe COVID-19. The benefit-risk relationship of mRNA- 1273 vaccine / Moderna COVID-19 Vaccine is not affected by this report.; Sender's Comments: This case concerns a 88-year-old male patient with no details on relevant medical history, who experienced the unexpected non serious event/AESI of COVID-19 after mRNA- 1273 Moderna vaccine (Moderna COVID-19 Vaccine / Spikevax). Additionally, Drug ineffective was captured. The event occurred approximately 8 months after the second dose of mRNA- 1273 vaccine with an appropriate schedule of vaccination (window between doses 26 days). The disease was mild, clinical manifestations were fatigue and asthenia. The rechallenge is not applicable due to the nature of the event . It is noted that patient´s age is a risk factor for severe COVID-19. The benefit-risk relationship of mRNA- 1273 vaccine / Moderna COVID-19 Vaccine is not affected by this report.
Recipient was identified post clinic when report was generated from data on vaccinations given. There was no phone number provided nor able to be found for me to call and talk to a parent to discuss this event and offer recommendations based on Moderna and CDC information on how to proceed. 2 others that week were found to have been under 18 and are being reported. It was the 3nd/3rd week Ct opened vaccination to anyone over 16. This age of course was intended for Pfizer only. We do not provide Pfizer. Subsequently signs were placed indicating a minimum age of 18, staff were reinforced to check age and an age calculation  based on birthdate and date of clinic was completed and included on the daily list of
"COVID arm" - large, red ring surrounding injection site. Slightly warmer than the rest of the body.  No other pain or itchiness.